ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
41.01
0.74%
US Tech 100
21,500.84
-0.12%
S&P 500
6,129.58
0.24%
US Dollar vs CAD
1.41863
0.00%
Bitcoin
94,389.72
-1.45%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NYSE

  6. Amneal Pharmaceuticals Holding Co (AMRX) Share Price

Amneal Pharmaceuticals Holding Co

Amneal Pharmaceuticals Holding Co (AMRX)

Amneal Pharmaceuticals Inc
5.87
0.00
( 0.00% )
Updated: 18:00:00
Delayed by 15 minutes

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Key stats and details

Current Price
5.87
Bid
-
Ask
-
Volume
-
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Market Cap
1.817B
Previous Close
5.87
Open
-
Last Trade
Last Trade Time
-
Financial Volume
-
VWAP
-
Average Volume (3m)
-
Shares Outstanding
309,542,608
Dividend Yield
-
PE Ratio
-21.64
Earnings Per Share (EPS)
-0.27
Revenue
2.41B
Net Profit
-83.99M

About Amneal Pharmaceuticals Holding Co

Amneal Pharmaceuticals Inc is a generic pharmaceutical manufacturer. The company's reportable segments are Generic Products, Specialty products, and AvKARE. The Generics segment develops, manufactures and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inha... Amneal Pharmaceuticals Inc is a generic pharmaceutical manufacturer. The company's reportable segments are Generic Products, Specialty products, and AvKARE. The Generics segment develops, manufactures and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products, and transdermals, and the Specialty segment is engaged in the development, promotion, sale and distribution of proprietary branded pharmaceutical products. The AvKARE segment provides pharmaceuticals, medical and surgical products, and services primarily to governmental agencies. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.amneal.com
Headquarters
Wilmington, Delaware, USA
Founded
-

Ask ADVFN Intelligence (AI)

AMRX Latest News

More News

Form 144 - Report of proposed sale of securities
Edgar (US Regulatory)
August 14 2024
AMRX (0.00%)

Form 144 - Report of proposed sale of securities
Edgar (US Regulatory)
August 14 2024
AMRX (0.00%)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

AMRX - Frequently Asked Questions (FAQ)

What is the current Amneal Pharmaceuticals share price?
The current share price of Amneal Pharmaceuticals is US$ 5.87
How many Amneal Pharmaceuticals shares are in issue?
Amneal Pharmaceuticals has 309,542,608 shares in issue
What is the market cap of Amneal Pharmaceuticals?
The market capitalisation of Amneal Pharmaceuticals is USD 1.82B
What is the 1 year trading range for Amneal Pharmaceuticals share price?
Amneal Pharmaceuticals has traded in the range of US$ 0.00 to US$ 0.00 during the past year
What is the PE ratio of Amneal Pharmaceuticals?
The price to earnings ratio of Amneal Pharmaceuticals is -21.64
What is the cash to sales ratio of Amneal Pharmaceuticals?
The cash to sales ratio of Amneal Pharmaceuticals is 0.75
What is the reporting currency for Amneal Pharmaceuticals?
Amneal Pharmaceuticals reports financial results in USD
What is the latest annual turnover for Amneal Pharmaceuticals?
The latest annual turnover of Amneal Pharmaceuticals is USD 2.41B
What is the latest annual profit for Amneal Pharmaceuticals?
The latest annual profit of Amneal Pharmaceuticals is USD -83.99M
What is the registered address of Amneal Pharmaceuticals?
The registered address for Amneal Pharmaceuticals is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the Amneal Pharmaceuticals website address?
The website address for Amneal Pharmaceuticals is www.amneal.com
Which industry sector does Amneal Pharmaceuticals operate in?
Amneal Pharmaceuticals operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
AAMAA Mission Acquisition Corp
US$ 0.00
(0.00%)
0
AACT.UAres Acquisition Corporation II
US$ 0.00
(0.00%)
0
AACTAres Acquisition Corporation II
US$ 0.00
(0.00%)
0
AAAlcoa Corporation
US$ 0.00
(0.00%)
0
AAgilent Technologies
US$ 0.00
(0.00%)
0
AAMAA Mission Acquisition Corp
US$ 0.00
(0.00%)
0
AACT.UAres Acquisition Corporation II
US$ 0.00
(0.00%)
0
AACTAres Acquisition Corporation II
US$ 0.00
(0.00%)
0
AAAlcoa Corporation
US$ 0.00
(0.00%)
0
AAgilent Technologies
US$ 0.00
(0.00%)
0
AAMAA Mission Acquisition Corp
US$ 0.00
(0.00%)
0
AACT.UAres Acquisition Corporation II
US$ 0.00
(0.00%)
0
AACTAres Acquisition Corporation II
US$ 0.00
(0.00%)
0
AAAlcoa Corporation
US$ 0.00
(0.00%)
0
AAgilent Technologies
US$ 0.00
(0.00%)
0

AMRX Discussion

View Posts
Monksdream Monksdream 10 months ago
AMRX under $10
👍️0
Monksdream Monksdream 11 months ago
AMRX under $10
👍️0
Luckypennyman Luckypennyman 2 years ago
Amarin Announces New REDUCE-IT® Data. March 5, 2023.

DUBLIN, Ireland and BRIDGEWATER, N.J., March 05, 2023 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced a new analysis from the VASCEPA/VAZKEPA (icosapent ethyl) cardiovascular outcomes REDUCE-IT study showing the effectiveness of VASCEPA®/VAZKEPA® in patients with recent acute coronary syndrome (<12 months before randomization). This post-hoc analysis showed that icosapent ethyl (IPE) substantially and significantly reduced the risk of first and total ischemic events by 37% and 36% respectively in patients with recent acute coronary syndrome (ACS) without increasing bleeding, supporting early initiation of IPE after ACS. The data were presented at the American College of Cardiology’s 72nd Annual Scientific Session together with the World Heart Federation’s World Congress of Cardiology in New Orleans, LA.

https://healthstockshub.com/news/nasdaq/amrn/amarin-announces-new-reduce-it-data-at-acc-23-wcc-showing-benefit-of-vascepa-vazkepa-icosapent-ethyl-in-high-risk-patients-with-a-recent-acute-coronary-syndrome-event
👍️0
Jake L Jake L 3 years ago
AMRX - Update

👍️0
TrendTrade2016 TrendTrade2016 4 years ago
monster bio beast ready to beast in beast land!!
👍️0
ClayTrader ClayTrader 4 years ago
* * $AMRX Video Chart 03-08-2021 * *

Link to Video - click here to watch the technical chart video

👍️0
ListenToMe ListenToMe 4 years ago
AMRX is a good long term hold.
👍️0
ListenToMe ListenToMe 4 years ago
I was hoping AMRX would have better news
👍️0
ListenToMe ListenToMe 4 years ago
Any opinions on AMRX for 2021?
👍️0
ListenToMe ListenToMe 4 years ago
AMRX... the time will come.!
👍️0
ListenToMe ListenToMe 4 years ago
Looks like amrx is going into the 3's
👍️0
ListenToMe ListenToMe 4 years ago
I agree AMRX needs a good catalyst to bring some well deserved attention to this company!

AMRX has huge potential!!
👍️0
Elpapibh Elpapibh 4 years ago
It’s a fantastic play, it’s just they’re in the background and no demand for shares can keep this where it’s at
👍️0
ListenToMe ListenToMe 4 years ago
I'm still thinking AMRX will be a great Sleeper play!!
👍️0
ListenToMe ListenToMe 4 years ago
AMRX is getting a little bounce today. nice
👍️0
Elpapibh Elpapibh 4 years ago
No demand, yet
👍️0
ListenToMe ListenToMe 4 years ago
I'm really surprised this thing isn't 4X Higher.

AMRX
👍️0
Elpapibh Elpapibh 4 years ago
Close to 2 bil market cap no reason for such a dip. Let’s see how the re-recovery looks.
👍️0
Elpapibh Elpapibh 4 years ago
Let’s see what these earnings dooo
👍️0
Elpapibh Elpapibh 4 years ago
Another snack of a close.!! Who’s riding this wave with me???
👍️0
Elpapibh Elpapibh 4 years ago
Fantastic close...
👍️0
Elpapibh Elpapibh 4 years ago
Did I jump on the train too late? I think not. Why isn’t this company forum more popping?
👍️0
ListenToMe ListenToMe 4 years ago
AMRX could be a doubler by end of year!
👍️0
ListenToMe ListenToMe 4 years ago
Amneal is a solid company and will pay off big.
👍️0
Bngo Bngo 4 years ago
With President Trump trying to bring API manufacturing back to The USA to help us rely less on China and India, hopefully all US drug manufacturers can all benefit from this move including Amneal.

Here is a good reason why Amneal is a great candidate for long term success.

https://investors.amneal.com/news/press-releases/press-release-details/2019/Amneal-to-Acquire-Majority-Interest-in-AvKARE-Enhancing-Access-to-Growing-Federal-Healthcare-Market/default.aspx
👍️0
dangerx dangerx 4 years ago
Nice week AMRX ??
👍️0
dangerx dangerx 4 years ago
Shorts and scares. Plus the whole generic pharmaceutical market has been in the crapper for years. Amneal has done great things during that time like launching high value generics and acquiring valuable manufacturers and distributors. It’s only a matter of time before their NDAs and bioequivalents start being major profit centers. Glad you’re on board with this little pharmaceutical company that could (and has!)
👍️0
ListenToMe ListenToMe 4 years ago
I agree AMRX is a big Winner!!
👍️0
Bngo Bngo 4 years ago
This should be a good reason why Amneal is a great candidate for long term success.


https://investors.amneal.com/news/press-releases/press-release-details/2019/Amneal-to-Acquire-Majority-Interest-in-AvKARE-Enhancing-Access-to-Growing-Federal-Healthcare-Market/default.aspx
👍️0
Bngo Bngo 4 years ago
I like the company with its promising government contract, but why are we still so far away from $182?
👍️0
ListenToMe ListenToMe 4 years ago
AMRX is my fav. Pharma play.
👍️0
ListenToMe ListenToMe 4 years ago
AMRX ... buy the dip.
Very solid company.
👍️0
ListenToMe ListenToMe 4 years ago
AMRX is a GREAT long-term play.
Many drugs in the pipeline, sales have been consistently increasing and its a US manufacturer.

WIN WIN WIN


AMRX
👍️0
ListenToMe ListenToMe 4 years ago
AMRX has huge potential. Positioned perfectly to capitalize on the rebirth of US drugs!
👍️0
dangerx dangerx 5 years ago
I think institutional investors might come to play too. I’m pretty sure it was over 90% last year and now 69% according to schwab. If that number grows I’ll have 0 worries here.
👍️0
ListenToMe ListenToMe 5 years ago
#FACT...$182 was the price target last year for AMRX. From at least TWO (2) major analysts.


AMRX = Big $$$$

👍️0
ListenToMe ListenToMe 5 years ago
As I was saying... AMRX is quietly laying the groundwork for significant developments!$$$


AMRX = Extremely Strong BUY$$$$....



BOOM
👍️0
ListenToMe ListenToMe 5 years ago
AMRX is just cruising along and laying low right now...BUT the day of recognition is coming!!$$

And it will be one of the Most talked about companies in the world ??!$$$

AMRX
👍️0
ListenToMe ListenToMe 5 years ago
Now you're talking!!
I like the sound of that.

AMRX is Awesome!!!
👍️0
dangerx dangerx 5 years ago
Shorts cover, approval for biosimilar meds, or Kodak’s grant gets cancelled and goes to AMRX instead.

I’d be happy with a short squeeze.
👍️0
ListenToMe ListenToMe 5 years ago
So I'm trying to figure out what would be a great catalyst to make AMRX surge to the next level above $20.00 range.

Hmmmmm
👍️0
ListenToMe ListenToMe 5 years ago
Lots of interest in AMRX.
👍️0
dangerx dangerx 5 years ago
Things haven’t even got going yet... This is just the tap water in the pot when you first turn on the burner.
👍️0
ListenToMe ListenToMe 5 years ago
And.... HERE WE GO!!$$$

amrx
👍️0
ListenToMe ListenToMe 5 years ago
Looking Very Strong!!

AMRX
👍️0
ListenToMe ListenToMe 5 years ago
Can't go wrong with AMRX!!!
👍️0
ListenToMe ListenToMe 5 years ago
Can't go wrong with AMRX!!!
👍️0
ListenToMe ListenToMe 5 years ago
AMRX... $5.00 - $10.00 - $50.00 - $100+ !!!$$$$
👍️0
ListenToMe ListenToMe 5 years ago
$182 was the price target last year for AMRX. From TWO major analysts.
👍️0
ListenToMe ListenToMe 5 years ago
Insiders are loading AMRX.

Value buyers are buying.

AMRX IS the Most undervalued pharma stock .
👍️0

Your Recent History

NYSE
AMRX
Amneal Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads